Torno Capital’s LAVA Therapeutics LVTX Stock Holding History
Bought
Maintained
Sold
Torno Capital's LVTX Position: Q4 2025 in Review
Torno Capital sold out of LAVA Therapeutics (LVTX) in Q4 2025, closing a stake of 15,000 shares — an estimated $23.4K sold.
Torno Capital first reported a position in LVTX in Q3 2025 and held it in 1 quarter. The position peaked at $23.4K in Q3 2025. 0 funds tracked by Wall St. Rank hold LVTX as of Q4 2025.
- Torno Capital reported no remaining LAVA Therapeutics position as of Q4 2025 after selling out during the quarter.
- Torno Capital sold 15,000 LAVA Therapeutics shares in Q4 2025, an estimated $23.4K.
- Torno Capital first reported a position in LAVA Therapeutics in Q3 2025 and held it in 1 quarter.
- Torno Capital's LAVA Therapeutics position peaked at $23.4K in Q3 2025.
- 0 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2025.
Based on Torno Capital's 13F filing for Q4 2025, filed 17 Feb 2026.